These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17189232)

  • 1. Gelatinous degeneration in a recipient of allogeneic bone marrow transplantation.
    Aisa Y; Mori T; Nakazato T; Yamazaki R; Ikeda Y; Okamoto S
    Int J Hematol; 2006 Dec; 84(5):465-7. PubMed ID: 17189232
    [No Abstract]   [Full Text] [Related]  

  • 2. Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis - was Demodex the culprit?
    Lotze C; Krüger WH; Kiefer T; Swensson O; Herbst EW; Schüler F; Busemann C; Dölken G
    Bone Marrow Transplant; 2006 Apr; 37(7):711-2. PubMed ID: 16474408
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complete regression of bone marrow fibrosis following allogeneic peripheral blood stem cell transplantation in a patient with idiopathic myelofibrosis].
    Benesová P; Dĕdic K; Zák P; Voglová J
    Cesk Patol; 2004 Oct; 40(4):167-71. PubMed ID: 15645853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].
    Dupriez B; Demory JL
    Rev Prat; 2005 Oct; 55(15):1680-5. PubMed ID: 16334205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myelofibrosis. Treatment with allogeneic bone marrow transplantation.
    Kroener JF; McMillan R; Beutler E
    JAMA; 1983 Mar; 249(9):1189-90. PubMed ID: 6337287
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphological aspects of myelofibrosis, observed in rats following sublethal whole body irradiation and subsequent allogeneic bone marrow cell transfusion.
    Stodtmeister R; Fliedner TM
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):23-50. PubMed ID: 4128514
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelofibrosis with myeloid metaplasia.
    Tefferi A
    N Engl J Med; 2000 Apr; 342(17):1255-65. PubMed ID: 10781623
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of severe bone marrow fibrosis and osteosclerosis following allogeneic bone marrow transplantation for chronic granulocytic leukaemia.
    McGlave PB; Brunning RD; Hurd DD; Kim TH
    Br J Haematol; 1982 Oct; 52(2):189-94. PubMed ID: 6751377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and management of idiopathic myelofibrosis.
    Smith BD; Moliterno AR
    Curr Opin Oncol; 2001 Mar; 13(2):91-4. PubMed ID: 11224705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation.
    Rajantie J; Sale GE; Deeg HJ; Amos D; Appelbaum F; Storb R; Clift RA; Buckner CD
    Blood; 1986 Jun; 67(6):1693-7. PubMed ID: 3518834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatomyositis developed in a recipient of allogeneic BMT; the differentiation of chronic GVHD and autoimmune disease.
    Sakamoto K; Imamura T; Niwa F; Komori S; Ishihara Y; Shiga K; Ito M; Hosoi H
    Bone Marrow Transplant; 2012 Apr; 47(4):603-4. PubMed ID: 21666739
    [No Abstract]   [Full Text] [Related]  

  • 13. Disseminated zygomycosis post allogeneic bone marrow transplantation.
    Kannan K; Ur-Rehman J; Rao TV; Jain R; Dennison D
    Am J Hematol; 2005 May; 79(1):68-9. PubMed ID: 15849768
    [No Abstract]   [Full Text] [Related]  

  • 14. Biopsy interpretation in bone marrow transplantation.
    Snover DC
    Pathol Annu; 1989; 24 Pt 2():63-101. PubMed ID: 2671885
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
    Kröger N; Thiele J; Zander A; Schwerdtfeger R; Kobbe G; Bornhäuser M; Bethge W; Schubert J; de Witte T; Kvasnicka HM;
    Exp Hematol; 2007 Nov; 35(11):1719-22. PubMed ID: 17976523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.
    Schmohl JU; Groh C; Faul C; Vogel W; Möhle R; Wirths S; Schneidawind D; Kanz L; Bethge WA
    Ann Hematol; 2016 May; 95(6):973-83. PubMed ID: 27021303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine Expression Pattern in Bone Marrow Microenvironment after Allogeneic Stem Cell Transplantation in Primary Myelofibrosis.
    Hussein K; Stucki-Koch A; Alchalby H; Triviai I; Kröger N; Kreipe H
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):644-650. PubMed ID: 26708839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of bone marrow angiogenesis in idiopathic myelofibrosis.
    Ni H; Barosi G; Hoffman R
    Am J Clin Pathol; 2006 Aug; 126(2):241-7. PubMed ID: 16891200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subleukemic myelosis - myelofibrosis].
    Demidova AV
    Ter Arkh; 1982; 54(9):135-43. PubMed ID: 7179142
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell-depleted allogeneic bone marrow transplantation in a case of childhood idiopathic myelofibrosis.
    Cahn JY; Plouvier E; Flesch M; Carbillet JP; Herve P
    Bone Marrow Transplant; 1987 Aug; 2(2):209-11. PubMed ID: 3332168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.